Horizon (HZNP) Gets Positive CHMP Opinion for Uplizna in NMOSD
Published on November 15, 2021
The CHMP gives a positive opinion on, and recommends approval to Horizon's (HZNP) Uplizna for treating adult patients with neuromyelitis optica spectrum disorder.